Understanding spontaneous pneumothorax in adolescents
Spontaneous Pneumothorax in Adolescents: Inventory and Management
This study looks at how spontaneous pneumothorax is treated in teenagers aged 14 to 20 who were treated at the University Hospitals of Strasbourg over the past decade.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 134 (estimated) |
| Ages | 14 Years to 20 Years |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT06175416 on ClinicalTrials.gov |
What this trial studies
This observational study aims to inventory the management of spontaneous pneumothorax in adolescents aged 14 to 20 years at the University Hospitals of Strasbourg. It focuses on patients who have experienced spontaneous pneumothorax without an apparent cause and have been treated at the hospital between 2010 and 2021. The study will analyze retrospective data to better understand treatment approaches and outcomes for this condition in the specified age group.
Who should consider this trial
Good fit: Ideal candidates for this study are adolescents aged 14-20 who have experienced spontaneous pneumothorax and were treated at the University Hospitals of Strasbourg.
Not a fit: Patients with secondary pneumothorax or those who have not been treated at the specified hospital may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the understanding and management of spontaneous pneumothorax in adolescents, leading to better treatment strategies.
How similar studies have performed: While there may be limited studies specifically focusing on adolescents with spontaneous pneumothorax, similar observational studies have provided valuable insights into the management of pneumothorax in general.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: * Adult patient (18-20 years old) * Minor patient aged 14-17 years old * Any gender * Spontaneous pneumothorax without apparent cause, between 14 and 20 years old * Patient operated on at the HUS between 2010 and 2021 * Patient not objecting to the reuse of their data for scientific research purposes. * Holders of parental authority who do not object to the reuse of their child's data for scientific research purposes. Exclusion criteria: * Patient who has expressed his opposition to the reuse of his data for scientific research purposes. * Holders of parental authority who have expressed their opposition to the reuse of their child's data for scientific research purposes. * Secondary origin of the pathology: Cystic fibrosis, postoperative pneumothorax, post-traumatic, * Subject having been treated initially in another structure without further information.
Where this trial is running
Strasbourg
- Service de Chirurgie pédiatrique - CHU de Strasbourg - France — Strasbourg, France (Recruiting)
Study contacts
- Study coordinator: Isabelle TALON, MD
- Email: Isabelle.TALON@chru-strasbourg.fr
- Phone: 33 3 88 12 72 96
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.